Agilent valuation
|
Use Agilent Technologies Inc valuation within your existing portfolios mixed with equities fromn New York Stock Exchange to protect against small markets fluctuations as well as to determine Stock diversification method that is right for you. Build Portfolio
Agilent Technologies Inc is presently expected to have enterprise value of 14.49 B with market capitalization of 14.34 B, debt of 2.36 B, and cash on hands of 2.45 B. Please note that enterprise value may be misleading and is a subject to accounting manipulations. We encourage investors to cautiously inspect all of the Agilent fundamentals before making security selection decision based on the enterprise value of the company
Agilent Investor InformationAbout 83.0% of the company shares are held by institutions. Book value of Agilent Technologies Inc was presently as 15.41. The company has Price/Earnings To Growth (PEG) ratio of 2.03. Agilent Technologies Inc last dividend was issued on March 28, 2013. Agilent Technologies, Inc. offer bioanalytical and electronic measurement solutions and services to the life sciences, chemical analysis, diagnostics and genomics, communications, and electronics industries worldwide. For more info on AGILENT TECH INC please contact William Sullivan at 408-345-8886 or go to http://www.home.agilent.com. Agilent Asset UtilizationAgilent Technologies Inc exercises its assets almost 6.85 percent, generating $0.07 for each dollar of assets held by the firm. A flourishing assets utilization indicates the company is being more effective with each dollar of assets it possesses. In plain English assets utilization of Agilent shows how effective it operates for each dollar spent on its assetsAgilent Ownership Allocation (%)Agilent holds a total of three hundred fourty-seven million one hundred sixty thousand outstanding shares. Majority of Agilent Technologies Inc outstanding shares are owned by other corporate entities. These outside corporations are referred to non-private investors that are looking to take positions in Agilent Technologies to benefit from reduced commissions. Consequently, institutional investers are subject to different set of regulations than regular investors in Agilent. Please pay attention to any change in the institutional holdings of Agilent Technologies Inc as this could imply that something significant has changed or about to change at the company. Please note that no matter how much assets the company secures, if the real value of the the firm is less than the current market value, you may not be able to make money on it.Agilent Profitability AnalysisThe company reported annual revenue of 6.9 B. Net Income to common stockholders was 1.1 B with gross profit before all taxes, overhead, and interest of 3.6 B. Agilent Debt AnalysisAGILENT TECH INC has accumulated about 2.45 B in cash with 1.32 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.06.
|
Agilent Market ShareAgilent Technologies Inc is rated fourth in market capitalization category among related companies. Market capitalization of Medical Laboratories and Research industry is presently estimated at about 112.5 Billion. Agilent retains roughly 14.34 Billion in market capitalization claiming about 13% of all equities under Medical Laboratories and Research industry.Follow Agilent Valuation with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker Agilent RevenueBased on latest financial disclosure Agilent Technologies Inc reported 6.9 B of revenue. This is 49.3% higher than that of Healthcare sector, and 574.84% higher than that of Medical Laboratories and Research industry, The Revenue for all stocks is 13.47% higher than the company. |